These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10734687)

  • 1. [The use of the vasoconstrictor hemostatic Remestyp in surgical obstetrics].
    Dimitrov A
    Akush Ginekol (Sofiia); 1999; 38(3):58-60. PubMed ID: 10734687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The active management of the placental period with Remestyp].
    Dimitrov A; Nikolov A; Krŭsteva K; Lazarova L; Gŭrchev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):15-7. PubMed ID: 10726344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of Remestyp in the paediatric gynecology treating juvenile metrorrhagia (author's transl)].
    Horejsi J
    Cesk Gynekol; 1980 Jun; 45(5):292-4. PubMed ID: 7397832
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between lysine vasopressin and a long-acting analogue (N alpha-triglycyl-lysine vasopressin) used as local hemostatic agents for conization.
    Rundqvist E; Allen D; Larsson G
    Acta Obstet Gynecol Scand; 1988; 67(4):301-5. PubMed ID: 3051878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of Remestip for genital hemorrhages in pubescent youth].
    Sirakov M
    Akush Ginekol (Sofiia); 2000; 40 Suppl 3():17-8. PubMed ID: 11519225
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy.
    Laudański T; Akerlund M
    Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin--more than just a prodrug of lysine vasopressin?
    Westphal M; Rehberg S; Ertmer C; Morelli A
    Crit Care Med; 2009 Mar; 37(3):1135-6. PubMed ID: 19237933
    [No Abstract]   [Full Text] [Related]  

  • 9. Conservative management of post-partum hemorrhage secondary to placenta previa-accreta with hypogastric artery ligation and endo-uterine hemostatic suture.
    Rauf M; Ebru C; Sevil E; Selim B
    J Obstet Gynaecol Res; 2017 Feb; 43(2):265-271. PubMed ID: 27987348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of triglycyl-lysine-vasopressin on skin blood flow and blood loss during wound excision in patients with burns.
    Garner WL; Thomson PD; Moore NP; Rodriguez JL; Smith DJ
    J Burn Care Rehabil; 1993; 14(4):458-60. PubMed ID: 8408173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe hyponatraemia to terlipressin treatment].
    Poulsen A; Krag A
    Ugeskr Laeger; 2013 Sep; 175(39):2250-1. PubMed ID: 24063710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of major postpartum hemorrhage].
    Nebout S; Merbai N; Faitot V; Keita H
    Presse Med; 2014 Feb; 43(2):111-7. PubMed ID: 24373716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy.
    Ari E; Yilmaz Y; Kedrah AE; Alahdab Y; Cakalagaoglu F; Arikan H; Kocak H; Macunluoglu B; Atakan A; Kahveci A; Asicioglu E; Tuglular S; Ozener C
    Am J Nephrol; 2011; 33(3):269-76. PubMed ID: 21372562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin in brain-death donors.
    Piazza O; Scarpati G; Rispoli F; Iannuzzi M; Tufano R; De Robertis E
    Clin Transplant; 2012; 26(6):E571-5. PubMed ID: 23121213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of ischemic skin necrosis after glypressin therapy in liver cirrhosis.
    Oh JE; Ha JS; Cho DH; Yu GJ; Shim SG
    Korean J Gastroenterol; 2008 Jun; 51(6):381-4. PubMed ID: 18604141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: future indications for terlipressin therapy.
    Lebrec D
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():65-7; discussion 68. PubMed ID: 15335406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin in hepatorenal syndrome.
    Mazur JE; Cooper TB; Dasta JF
    Ann Pharmacother; 2011 Mar; 45(3):380-7. PubMed ID: 21386023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of terlipressin (Remestyp Spofa) on hemodynamic parameters in patients with portal hypertension associated with liver cirrhosis].
    Cervinka J; Kaláb M; Jedlicka J; Petrtýl J; Srnský J; Marecek Z; Kordac V; Vrána J
    Cas Lek Cesk; 1989 Jul; 128(28):868-71. PubMed ID: 2790879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Terlipressin acetate].
    Becker PU; Bendtsen F
    Ugeskr Laeger; 1997 Sep; 159(36):5399-402. PubMed ID: 9304275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.